Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is excited to announce the appointment of Ms. Egle Gedrimaite, as the new Head of Global Business Development, effective October 1, 2024.

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Adventures in Lifelong Learning begins its spring 2024 season on Sept. 24 and will continue from 10 to 11:30 a.m. each Tuesday through Nov. 12, at t Eagles Club, 1270 Neilson Ave. SE. The season kicks ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

The Minnesota Vikings will induct former CB Bobby Bryant into the club’s Ring of Honor during halftime this Sunday, September ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic was one I remember. There were other big companies that went there. And I think that there has been a kibosh put on companies trying to do that now. One of the fascinating things about the ...

Rakuten Medical Inc. has presented preclinical results with RM-0256, a PD-L1-targeted photoimmunotherapy, showing its ability ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Worrell said the treatment process for breast cancer takes anywhere from three to six months. It took her friend years to ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...